Skip to Main Content
Services Talent Knowledge
Site Search
Menu

News

June 25, 2018

Gabe Nugent Featured in Stat News Podcast on Theranos Fraud

Gabe Nugent, White Collar Practice Area co-chair and partner, was recently featured in Stat News' podcast episode "Sarepta's Big Week, Theranos' Legal Woes, and Parsing AI Hype," commenting on the fraud scandal involving Silicon Valley health care company Theranos and its founder Elizabeth Holmes and president Ramesh "Sunny" Balwani.

Nugent explained that Theranos is "a special case" when it comes to fraud largely because Holmes and Balwani didn't just commit fraud against investors, but against patients and doctors.

"What you have are people whose lives were played with," Nugent said. "So, it essentially creates a sympathy vacuum." This may influence the duo's sentencing if convicted, potentially resulting in a longer prison stay than cited fraudsters Bernie Madoff and Martin Shkreli.

Listen to the full podcast here.

Subscribe

Click here to sign up for alerts, blog posts, and firm news.

Featured Media

Alerts

Website Accessibility Lawsuits: Several "Tester" Plaintiffs—Tavon Turner, Damian Martin, Jeffrey Martinez, Teniya Booker, and Jason Camacho—Targeting Businesses in Recent Flurry of Lawsuits

Alerts

Supreme Court to Clarify Article III Injury Requirement for Class Certification

Alerts

NYS Governor Kathy Hochul Proposes Changes to New York's Involuntary Commitment Laws – What You Need to Know, Part 1

Alerts

Federal Air Safety Regulations Do Not Preempt NYS Labor Law Claims in Helicopter Crash Case

Alerts

Corporate Transparency Act Enforcement Remains Paused After Supreme Court Ruling

Alerts

Bankruptcy Avoidance Actions, Part 1 – Preferential Transfers

This site uses cookies to give you the best experience possible on our site and in some cases direct advertisements to you based upon your use of our site.

By clicking [I agree], you are agreeing to our use of cookies. For information on what cookies we use and how to manage our use of cookies, please visit our Privacy Statement.

I AgreeOpt-Out